Ashoo Gupta
Vermogen: 466 315 $ op 31-05-2026
Vermogen: 466 315 $ op 31-05-2026
Ashoo Gupta is Controller & Vice President-Finance at 4D Molecular Therapeutics, Inc. since 2026.
Formerly, Mr. Gupta was Vice President-Finance & Controller at Kyverna Therapeutics, Inc. from 2023 to 2024.
Mr. Gupta completed undergraduate education at the University of Mumbai.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 20-03-2026 | 47.055 ( 0,09% ) | 466 315 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| 4D MOLECULAR THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 01-06-2024 |
| Bedrijven | Functie | Einde |
|---|---|---|
| KYVERNA THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 01-06-2024 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 3 |
|---|---|
University of Mumbai
University of Mumbai Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
4D Molecular Therapeutics, Inc.
4D Molecular Therapeutics, Inc. BiotechnologyHealth Technology Designs, develops and commercializes transformative gene therapeutic products for serious unmet medical conditions | Health Technology |
Kyverna Therapeutics, Inc.
Kyverna Therapeutics, Inc. BiotechnologyHealth Technology Operates as a cell therapy company which develops treatments and potential cures for serious autoimmune diseases | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau